Doximity (DOCS) Cost of Revenue (2020 - 2026)

Doximity (DOCS) has 7 years of Cost of Revenue data on file, last reported at $112.7 million in Q1 2026.

• Quarterly Cost of Revenue rose 199.72% year-over-year to $112.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $230.5 million (up 58.17% YoY) and the FY2026 annual result came in at $163.6 million, up 12.31% from the prior year.
• Cost of Revenue climbed to $112.7 million in Q1 2026 per DOCS's latest filing, from $42.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $112.7 million in Q1 2026 and bottomed at $12.2 million in Q4 2023.
• The 5-year median for Cost of Revenue is $34.4 million (2024), against an average of $33.1 million.
• Peak annual rise in Cost of Revenue reached 215.76% in 2024, while the deepest fall reached 62.09% in 2024.
• Tracing DOCS's Cost of Revenue over 5 years: stood at $13.5 million in 2022, then retreated by 9.88% to $12.2 million in 2023, then soared by 215.76% to $38.5 million in 2024, then grew by 9.65% to $42.2 million in 2025, then jumped by 167.1% to $112.7 million in 2026.
• Per Business Quant, the three latest DOCS Cost of Revenue figures stand at $112.7 million (Q1 2026), $42.2 million (Q4 2025), and $39.2 million (Q3 2025).

Peer Comparison